No Data
No Data
Express News | AbbVie Shares Are Trading Higher After Multiple Analysts Raised Their Price Targets on the Stock. The Company Last Week Reported Better-than-expected Q1 Financial Results and Raised Its FY25 Adjusted EPS Guidance
Express News | Evercore ISI Group Maintains Outperform on AbbVie, Raises Price Target to $205
Morgan Stanley Maintains Overweight on AbbVie, Raises Price Target to $250
AbbVie Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Tvardi Therapeutics (TVRD) and AbbVie (ABBV)
Raymond James Adjusts Price Target on AbbVie to $227 From $220, Maintains Outperform Rating
MOHD NOR B ABDULLAH : ok
74128907 :![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)